Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review

Paola Alberti, Sara Faithfull, Andreas A. Argyriou, David Balayssac, Daniel L. Hertz, Maryam Lustberg, Susanna B. Park, Tiffany Li, Mary Tanay, Terri Jabaley, Lise Worthen-Chaudhari, Ellen M. L. Smith, Unknown

Open source

DOI
10.1007/s00520-026-10690-2
Published
2026-05-07
Container
Supportive Care in Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00520-026-10690-2,
  title = {Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review},
  author = {Paola Alberti and Sara Faithfull and Andreas A. Argyriou and David Balayssac and Daniel L. Hertz and Maryam Lustberg and Susanna B. Park and Tiffany Li and Mary Tanay and Terri Jabaley and Lise Worthen-Chaudhari and Ellen M. L. Smith and Unknown},
  year = {2026},
  journal = {Supportive Care in Cancer},
  doi = {10.1007/s00520-026-10690-2},
  url = {https://doi.org/10.1007/s00520-026-10690-2}
}

RIS

TY  - JOUR
TI  - Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review
AU  - Paola Alberti
AU  - Sara Faithfull
AU  - Andreas A. Argyriou
AU  - David Balayssac
AU  - Daniel L. Hertz
AU  - Maryam Lustberg
AU  - Susanna B. Park
AU  - Tiffany Li
AU  - Mary Tanay
AU  - Terri Jabaley
AU  - Lise Worthen-Chaudhari
AU  - Ellen M. L. Smith
AU  - Unknown
PY  - 2026
JO  - Supportive Care in Cancer
DO  - 10.1007/s00520-026-10690-2
UR  - https://doi.org/10.1007/s00520-026-10690-2
ER  - 

APA

Alberti, P., Faithfull, S., Argyriou, A. A., Balayssac, D., Hertz, D. L., Lustberg, M., Park, S. B., Li, T., Tanay, M., Jabaley, T., Worthen-Chaudhari, L., Smith, E. M. L., & Unknown (2026). Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review. Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-10690-2

Source records